Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05633225

Central Sensitization and Physical Activity in Adolescents With HSD/hEDS

Hypermobile Ehlers-Danlos Syndrome Clinical Trial

Official title:
Measuring Central Sensitization and Physical Activity in Adolescents With Hypermobility Spectrum Disorder or Hypermobile Ehlers-Danlos Syndrome

Clinical Trial Summary

Hypermobility Spectrum Disorder and hypermobile Ehlers-Danlos Syndrome (HSD/hEDS) is under-recognized and poorly understood and its management is therefore not clear. The goal of this study is to better understand pain and its impact on function in the daily activities of adolescents with Hypermobility Spectrum Disorder and/or hypermobile Ehlers-Danlos Syndrome. This study will explore the presence of the pain sensitivity status after physical exercise as well as movement behaviour in adolescents with HSD/hEDS compared to a healthy control group.

Clinical Trial Description

All participants will be asked not to undertake physical exercise at least 48 hours before the measurements, and to refrain from consuming caffeine, alcohol or nicotine. For ethical reasons, the patients are allowed to take non-opioid pain medicine as described in the first step of the World Health Organization analgesic ladder (COX-inhibitors and paracetamol), however the patients will be asked to abstain from these medications during the 24 hours period before the measurements. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05633225
Study type Observational
Source Vastra Gotaland Region
Contact
Status Completed
Phase
Start date November 25, 2022
Completion date October 31, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT05000151 - Lung Volume Perception and Impact of a Cognitive Task on Ventilation in Hypermobile Ehlers-Danlos Syndrome.
Enrolling by invitation NCT05434728 - Characterization of Bleeding Disorders in EDS
Terminated NCT04666896 - Patient-based Care Versus Standard Care for Patients With hEDS/HSD and Multidirectional Shoulder Instability N/A
Recruiting NCT05405257 - Oxytocin for Hypermobile Ehlers-Danlos Syndrome Phase 1/Phase 2
Recruiting NCT05685199 - Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
Recruiting NCT06105541 - Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation N/A
Recruiting NCT05757960 - TMD-specific Physiotherapy in hEDS Patients Individuals With Hypermobile Ehlers-Danlos Syndrome N/A
Completed NCT05148039 - Comprehensive Assessment of Nutrition and Dietary Intervention in Hypermobile Ehlers Danlos Syndrome N/A
Recruiting NCT05212129 - Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome N/A
Completed NCT05800262 - Dynamic Stability Exercises in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder N/A